Sponsor Pipeline

BetaGlue Therapeutics SpA Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07155850 Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment… Pancreatic Ductal Adenocarcinoma (PDAC) Recruiting
Disease Areas
Pancreatic Cancer (1)
Get alerts when BetaGlue Therapeutics SpA's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free